HLHIX Mutual Fund

NAV$27.98

Fund Essentials - as of Sep 30, 2025

Net Assets
$5M
Expense Ratio
1.05%
Dividend Yield (Current)
-
Holdings
24
Inception Date
Dec 22, 2014
Fund Family
Virtus Investment Partners
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+0.78%
1 Year+3.87%
3 Year+3.94%
5 Year+8.85%
10 Year+10.79%

Asset Allocation

Stocks: 100.00%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.63%
ABBVAbbvie Inc6.32%
IDXXIdexx Laboratories Inc Common Stock Usd 0.16.22%
MCKMckesson Corp4.85%
ISRGINTUITIVE SURG4.61%
Top 10 Concentration: 56.37%Report Date: Sep 30, 2025
Download all 24 holdings for HLHIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$7.49
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HLHIX Mutual Fund Overview

HLHIX Mutual Fund (Virtus KAR Health Sciences Fund Institutional Class) is managed by Virtus Investment Partners with $5.0M in net assets. HLHIX expense ratio is 1.05%, holding 24 positions across sectors including Health Care, Unknown, Consumer Staples. Inception date: 2014-12-22.

HLHIX performance shows a YTD return of 0.78%. The 1-year return is 3.87% and the 5-year return is 8.85%.

HLHIX top holdings include Eli Lilly & Co (13.6%), Abbvie Inc (6.3%), Idexx Laboratories Inc Common Stock Usd 0.1 (6.2%), Mckesson Corp (4.8%), INTUITIVE SURG (4.6%). View all HLHIX holdings, sector breakdown, or dividend history.

HLHIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HLHIX alternatives are available via the screener, along with tax-loss harvesting opportunities.